Epigenetic Dysregulation at the Crossroad of Women's Cancer.

In the case of breast cancer, there is a clear trend of increased incidences in the 20–49 year age group and in the 50–64 year age group consistently for the past ten years with no evidence of decrease.

also in 19,460 other papers